Abstract

There is no abstract for this article. The text below is the first paragraph of text within the article.

The development of a vaccine to prevent the build-up of atherosclerotic plaque has come a step closer. Researchers at the Cedars-Sinai Medical Center (Los Angeles, CA, USA) and Lund University (Malmo, Sweden) have tested a peptide-based vaccine that reduces arterial plaque formation in mice by up to 70% [1]. Developing effective therapies for atherosclerosis is important because the disease is the root cause of more than half of all deaths in the developed world (http://www.atherosclerosis-drug.com).